{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:43:59Z","timestamp":1786981439914,"version":"build-2736575974"},"reference-count":19,"publisher":"Pharmaceutical Society of Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2023,2,1]]},"DOI":"10.1248\/bpb.b22-00529","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T22:12:19Z","timestamp":1675203139000},"page":"177-186","source":"Crossref","is-referenced-by-count":13,"title":["3-Nitropropionic Acid Enhances Ferroptotic Cell Death &lt;i&gt;via&lt;\/i&gt; NOX2-Mediated ROS Generation in STHdhQ111 Striatal Cells Carrying Mutant Huntingtin"],"prefix":"10.1248","volume":"46","author":[{"given":"Noria","family":"Okada","sequence":"first","affiliation":[{"name":"Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamitsu","family":"Shimazawa","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) MacDonald M. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. <i>Cell<\/i>, <b>72<\/b>, 971\u2013983 (1993).","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Wexler NS, Lorimer J, Porter J, <i>et al.<\/i> Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>101<\/b>, 3498\u20133503 (2004).","DOI":"10.1073\/pnas.0308679101"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Gusella JF, MacDonald ME. Huntington\u2019s disease: the case for genetic modifiers. <i>Genome Med.<\/i>, <b>1<\/b>, 80 (2009).","DOI":"10.1186\/gm80"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kwon D. Failure of genetic therapies for Huntington\u2019s devastates community. <i>Nature<\/i>, <b>593<\/b>, 180 (2021).","DOI":"10.1038\/d41586-021-01177-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. <i>Cell<\/i>, <b>87<\/b>, 493\u2013506 (1996).","DOI":"10.1016\/S0092-8674(00)81369-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Brouillet E, Jacquard C, Bizat N, Blum D. 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington\u2019s disease. <i>J. Neurochem.<\/i>, <b>95<\/b>, 1521\u20131540 (2005).","DOI":"10.1111\/j.1471-4159.2005.03515.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Bogdanov MB, Ferrante RJ, Kuemmerle S, Klivenyi P, Beal MF. Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington\u2019s disease. <i>J. Neurochem.<\/i>, <b>71<\/b>, 2642\u20132644 (1998).","DOI":"10.1046\/j.1471-4159.1998.71062642.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Okada N, Yako T, Nakamura S, Shimazawa M, Hara H. Reduced mitochondrial complex II activity enhances cell death <i>via<\/i> intracellular reactive oxygen species in STHdhQ111 striatal neurons with mutant huntingtin. <i>J. Pharmacol. Sci.<\/i>, <b>147<\/b>, 367\u2013375 (2021).","DOI":"10.1016\/j.jphs.2021.09.001"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Mi Y, Gao X, Xu H, Cui Y, Zhang Y, Gou X. The emerging roles of ferroptosis in Huntington\u2019s disease. <i>Neuromolecular Med.<\/i>, <b>21<\/b>, 110\u2013119 (2019).","DOI":"10.1007\/s12017-018-8518-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Klepac N, Relja M, Klepac R, He\u0107imovi\u0107 S, Babi\u0107 T, Trkulja V. Oxidative stress parameters in plasma of Huntington\u2019s disease patients, asymptomatic Huntington\u2019s disease gene carriers and healthy subjects. <i>J. Neurol.<\/i>, <b>254<\/b>, 1676\u20131683 (2007).","DOI":"10.1007\/s00415-007-0611-y"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Lee J, Kosaras B, Del Signore SJ, Cormier K, McKee A, Ratan RR, Kowall NW, Ryu H. Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington\u2019s disease mice. <i>Acta Neuropathol.<\/i>, <b>121<\/b>, 487\u2013498 (2011).","DOI":"10.1007\/s00401-010-0788-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Chen J, Marks E, Lai B, Zhang Z, Duce JA, Lam LQ, Volitakis I, Bush AI, Hersch S, Fox JH. Iron accumulates in Huntington\u2019s disease neurons: protection by deferoxamine. <i>PLOS ONE<\/i>, <b>8<\/b>, e77023 (2013).","DOI":"10.1371\/journal.pone.0077023"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, Persichetti F, Cattaneo E, MacDonald ME. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. <i>Hum. Mol. Genet.<\/i>, <b>9<\/b>, 2799\u20132809 (2000).","DOI":"10.1093\/hmg\/9.19.2799"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Dikalov S. Cross talk between mitochondria and NADPH oxidases. <i>Free Radic. Biol. Med.<\/i>, <b>51<\/b>, 1289\u20131301 (2011).","DOI":"10.1016\/j.freeradbiomed.2011.06.033"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Deshpande SB, Hida H, Takei-Io N, Masuda T, Baba H, Nishino H. Involvement of nitric oxide in 3-nitropropionic acid-induced striatal toxicity in rats. <i>Brain Res.<\/i>, <b>1108<\/b>, 205\u2013215 (2006).","DOI":"10.1016\/j.brainres.2006.06.032"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kumar P, Kumar A. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington\u2019s like symptoms in rats: possible role of nitric oxide. <i>Behav. Brain Res.<\/i>, <b>206<\/b>, 38\u201346 (2010).","DOI":"10.1016\/j.bbr.2009.08.028"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira AH. Mitochondrial defect in Huntington\u2019s disease caudate nucleus. <i>Ann. Neurol.<\/i>, <b>39<\/b>, 385\u2013389 (1996).","DOI":"10.1002\/ana.410390317"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R, Tang D. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. <i>Hepatology<\/i>, <b>63<\/b>, 173\u2013184 (2016).","DOI":"10.1002\/hep.28251"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Jin YN, Yu YV, Gundemir S, Jo C, Cui M, Tieu K, Johnson GV. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin. <i>PLOS ONE<\/i>, <b>8<\/b>, e57932 (2013).","DOI":"10.1371\/journal.pone.0057932"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/46\/2\/46_b22-00529\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T03:22:52Z","timestamp":1675480972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/46\/2\/46_b22-00529\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b22-00529","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"article-number":"b22-00529"}}